Dr. Kyle Cuneo studied Biological Engineering at Cornell University in Ithaca, NY. He then enrolled at Vanderbilt University School of Medicine in Nashville, TN, earning his Doctor of Medicine degree in 2007. Dr. Cuneo performed his intern year in Internal Medicine at Vanderbilt University in 2008. He completed his residency in Radiation Oncology at Duke University Medical Center in 2012. Dr. Cuneo has been faculty at the University of Michigan since 2012. Dr. Cuneo is a member of the multidisciplinary teams managing patients with hepatobiliary cancers, colorectal cancers, lymphomas, and sarcomas.

Dr. Cuneo performs translational and clinical research in gastrointestinal malignancies including liver, pancreas, and colorectal cancers. He has published over 80 scientific articles in the field of oncology. Dr. Cuneo has served as Chair of the Protocol Review Committee and the GI Clinical Research Team at the Rogel Cancer Center. He has been awarded Teacher of the Year for Clinical Radiation Oncology and Radiation Biology.

- Use of novel technologies and radiation sensitizers in gastrointestinal cancers
- Clinical trial design and implementation
- Liver Cancer
- Pancreas Cancer
- Colorectal Cancer
- Lymphoma
- Cutaneous Lymphoma
- Sarcoma
- Stereotactic Radiation Therapy